Clinical trial
Contrast-enhanced Ultrasound in Breast Tumor by Sonazoid
NCT04657328 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Contrast-enhanced Ultrasound in Breast Tumor by Sonazoid
- Lead sponsor
- Chinese PLA General Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 15, 2020
- Completion date
- October 31, 2021
- Enrollment
- 181 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ultrasound